Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Receivables - Other (2017 - 2022)

Historic Receivables - Other for Haemonetics (HAE) over the last 7 years, with Q4 2022 value amounting to $6.6 million.

  • Haemonetics' Receivables - Other rose 2000.0% to $6.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $6.6 million, marking a year-over-year increase of 2000.0%. This contributed to the annual value of $5.5 million for FY2022, which is 1458.33% up from last year.
  • Per Haemonetics' latest filing, its Receivables - Other stood at $6.6 million for Q4 2022, which was up 2000.0% from $7.6 million recorded in Q4 2022.
  • Over the past 5 years, Haemonetics' Receivables - Other peaked at $10.5 million during Q4 2018, and registered a low of $4.0 million during Q2 2018.
  • Moreover, its 5-year median value for Receivables - Other was $5.6 million (2019), whereas its average is $6.1 million.
  • Per our database at Business Quant, Haemonetics' Receivables - Other skyrocketed by 14761.9% in 2018 and then plummeted by 3432.84% in 2021.
  • Over the past 5 years, Haemonetics' Receivables - Other (Quarter) stood at $10.5 million in 2018, then fell by 23.81% to $8.0 million in 2019, then plummeted by 32.5% to $5.4 million in 2020, then decreased by 18.52% to $4.4 million in 2021, then skyrocketed by 50.0% to $6.6 million in 2022.
  • Its Receivables - Other stands at $6.6 million for Q4 2022, versus $7.6 million for Q4 2022 and $6.4 million for Q3 2022.